TreeWAS – Variant ID: rs6435957

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z30.1 Insertion of (intra-uterine) contraceptive device	0.131	0.869	0.000
Z30 Contraceptive management	0.125	0.875	0.000
Z30.8 Other contraceptive management	0.117	0.883	0.000
Z30.3 Menstrual extraction	0.114	0.886	0.000
Z30.2 Sterilisation	0.109	0.891	0.000
Z30.5 Surveillance of (intra-uterine) contraceptive device	0.107	0.893	0.000
Z30.4 Surveillance of contraceptive drugs	0.090	0.910	0.000
Z30.9 Contraceptive management, unspecified	0.090	0.910	0.000
H34.2 Other retinal artery occlusions	0.000	0.926	0.074
D12.3 Transverse colon	0.073	0.927	0.000
Z30.0 General counselling and advice on contraception	0.057	0.943	0.000
H34 Retinal vascular occlusions	0.000	0.956	0.044
H34.9 Retinal vascular occlusion, unspecified	0.000	0.962	0.038
H34.8 Other retinal vascular occlusions	0.000	0.966	0.034
H34.0 Transient retinal artery occlusion	0.000	0.968	0.032
H34.1 Central retinal artery occlusion	0.000	0.969	0.031
Z89.5 Acquired absence of leg at or below knee	0.000	0.974	0.026
J44.8 Other specified chronic obstructive pulmonary disease	0.019	0.981	0.000
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.015	0.985	0.000
G40 Epilepsy	0.014	0.986	0.000
G40.9 Epilepsy, unspecified	0.014	0.986	0.000
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.013	0.987	0.000
D12.4 Descending colon	0.013	0.987	0.000
R59.9 Enlarged lymph nodes, unspecified	0.012	0.988	0.000
M94.88 Other specified disorders of cartilage (Other)	0.011	0.989	0.000
M94.8 Other specified disorders of cartilage	0.011	0.989	0.000
M94.86 Other specified disorders of cartilage (Lower leg)	0.011	0.989	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.011	0.989	0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.011	0.989	0.000
G40.5 Special epileptic syndromes	0.011	0.989	0.000
G40.4 Other generalised epilepsy and epileptic syndromes	0.010	0.989	0.000
Z89 Acquired absence of limb	0.000	0.990	0.010
Y52 Agents primarily affecting the cardiovascular system	0.010	0.990	0.000
Z89.6 Acquired absence of leg above knee	0.000	0.990	0.010
G40.8 Other epilepsy	0.010	0.990	0.000
Z86.1 Personal history of infectious and parasitic diseases	0.010	0.990	0.000
Y52.1 Calcium-channel blockers	0.010	0.990	0.000
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.009	0.990	0.000
L40.9 Psoriasis, unspecified	0.010	0.990	0.000
M94.89 Other specified disorders of cartilage (Site unspecified)	0.009	0.991	0.000
Y52.7 Peripheral vasodilators	0.009	0.991	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.009	0.991	0.000
R47.8 Other and unspecified speech disturbances	0.009	0.991	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.009	0.991	0.000
C18.5 Splenic flexure	0.009	0.991	0.000
G40.7 Petit mal, unspecified, without grand mal seizures	0.009	0.991	0.000
M94.85 Other specified disorders of cartilage (Pelvic region and thigh)	0.009	0.991	0.000
C18.0 Caecum	0.009	0.991	0.000
C18.9 Colon, unspecified	0.008	0.992	0.000
M94.84 Other specified disorders of cartilage (Hand)	0.008	0.992	0.000
M94.83 Other specified disorders of cartilage (Forearm)	0.008	0.992	0.000
M94.82 Other specified disorders of cartilage (Upper arm)	0.008	0.992	0.000
M94.81 Other specified disorders of cartilage (Shoulder region)	0.008	0.992	0.000
M94.80 Other specified disorders of cartilage (Multiple sites)	0.008	0.992	0.000
Z89.9 Acquired absence of limb, unspecified	0.000	0.992	0.008
M94.87 Other specified disorders of cartilage (Ankle and foot)	0.008	0.992	0.000
Y45.1 Salicylates	0.008	0.992	0.000
Z89.7 Acquired absence of both lower limbs [any level, except toes alone]	0.000	0.992	0.008
R47.0 Dysphasia and aphasia	0.008	0.992	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.008	0.992	0.000
C18 Malignant neoplasm of colon	0.008	0.992	0.000
Z89.3 Acquired absence of both upper limbs [any level]	0.000	0.992	0.008
Z89.1 Acquired absence of hand and wrist	0.000	0.992	0.008
Z89.2 Acquired absence of upper limb above wrist	0.000	0.992	0.008
R47 Speech disturbances, not elsewhere classified	0.008	0.992	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.007	0.992	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.007	0.993	0.000
C18.2 Ascending colon	0.007	0.993	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.007	0.993	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.007	0.993	0.000
Z89.8 Acquired absence of upper and lower limbs [any level]	0.000	0.993	0.007
C18.8 Overlapping lesion of colon	0.007	0.993	0.000
M50.2 Other cervical disk displacement	0.007	0.993	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.007	0.993	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.007	0.993	0.000
Y45.2 Propionic acid derivatives	0.007	0.993	0.000
Y42.5 Other oestrogens and progestogens	0.007	0.993	0.000
C18.4 Transverse colon	0.007	0.993	0.000
M94 Other disorders of cartilage	0.007	0.993	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.006	0.994	0.000
Z89.0 Acquired absence of finger(s) [including thumb], unilateral	0.000	0.994	0.006
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.006	0.994	0.000
Y45.8 Other analgesics and antipyretics	0.006	0.994	0.000
M77.47 Metatarsalgia-Ankle/Foot	0.000	0.994	0.006
Y44 Agents primarily affecting blood constituents	0.006	0.994	0.000
D12 Benign neoplasm of colon, rectum, anus and anal canal	0.006	0.994	0.000
Z30-Z39 Persons encountering health services in circumstances related to reproduction	0.006	0.994	0.000
Y59 Other and unspecified vaccines and biological substances	0.006	0.994	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.006	0.994	0.000
R47.1 Dysarthria and anarthria	0.006	0.994	0.000
Y40 Systemic antibiotics	0.006	0.994	0.000
C18.3 Hepatic flexure	0.006	0.994	0.000
M94.9 Disorder of cartilage, unspecified	0.006	0.994	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.006	0.994	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.005	0.995	0.000
Y40.8 Other systemic antibiotics	0.005	0.995	0.000
Y42.9 Other and unspecified hormone antagonists	0.005	0.995	0.000
M94.0 Chondrocostal junction syndrome [Tietze]	0.005	0.995	0.000
Y58 Bacterial vaccines	0.005	0.995	0.000
Z39 Postpartum care and examination	0.005	0.995	0.000
Y45.4 Antirheumatics	0.005	0.995	0.000
Y54.5 Other diuretics	0.005	0.995	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.005	0.995	0.000
Y40.3 Macrolides	0.005	0.995	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.005	0.995	0.000
Y44.6 Natural blood and blood products	0.005	0.995	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.005	0.995	0.000
Z31 Procreative management	0.005	0.995	0.000
Z31.4 Procreative investigation and testing	0.005	0.995	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
M94.3 Chondrolysis	0.005	0.995	0.000
M94.1 Relapsing polychondritis	0.005	0.995	0.000
Y40.6 Rifamycins	0.005	0.995	0.000
Y59.3 Immunoglobulin	0.005	0.995	0.000
M94.96 Disorder of cartilage, unspecified (Lower leg)	0.005	0.995	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.005	0.995	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.005	0.995	0.000
Y54.8 Agents affecting uric acid metabolism	0.005	0.995	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.005	0.995	0.000
R93.8 Abnormal findings on diagnostic imaging of other specified body structures	0.005	0.995	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.005	0.995	0.000
Y42.1 Thyroid hormones and substitutes	0.005	0.995	0.000
S64.2 Injury of radial nerve at wrist and hand level	0.005	0.995	0.000
Z39.1 Care and examination of lactating mother	0.005	0.995	0.000
D12.2 Ascending colon	0.005	0.995	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.005	0.995	0.000
Y40.4 Tetracyclines	0.005	0.995	0.000
Y42.4 Oral contraceptives	0.005	0.995	0.000
M65.34 Trigger finger-Hand	0.000	0.995	0.005
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.005	0.995	0.000
Z35.0 Supervision of pregnancy with history of infertility	0.005	0.995	0.000
Y45.5 4-Aminophenol derivatives	0.004	0.995	0.000
Z89.4 Acquired absence of foot and ankle	0.000	0.995	0.004
Y56.3 Emollients, demulcents and protectants	0.004	0.996	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.004	0.996	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.004	0.996	0.000
Y44.7 Plasma substitutes	0.004	0.996	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.004	0.996	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.004	0.996	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.004	0.996	0.000
Y59.9 Vaccine or biological substance, unspecified	0.004	0.996	0.000
Y59.8 Other specified vaccines and biological substances	0.004	0.996	0.000
Y59.2 Protozoal vaccines	0.004	0.996	0.000
Y59.1 Rickettsial vaccines	0.004	0.996	0.000
Y59.0 Viral vaccines	0.004	0.996	0.000
Y40.7 Antifungal antibiotics, systemically used	0.004	0.996	0.000
L40 Psoriasis	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
H30-H36 Disorders of choroid and retina	0.000	0.996	0.004
N71.1 Chronic inflammatory disease of uterus	0.000	0.996	0.004
Y56.9 Topical agent, unspecified	0.004	0.996	0.000
Y56.8 Other topical agents	0.004	0.996	0.000
Y56.7 Dental drugs, topically applied	0.004	0.996	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.004	0.996	0.000
Y56.5 Ophthalmological drugs and preparations	0.004	0.996	0.000
Y56.2 Local astringents and local detergents	0.004	0.996	0.000
Y56.1 Antipruritics	0.004	0.996	0.000
Z31.8 Other procreative management	0.004	0.996	0.000
M94.09 Chondrocostal junction syndrome [Tietze]-Site unspec	0.004	0.996	0.000
Y40.2 Chloramphenicol group	0.004	0.996	0.000
M94.99 Disorder of cartilage, unspecified (Site unspecified)	0.004	0.996	0.000
M94.98 Disorder of cartilage, unspecified (Other)	0.004	0.996	0.000
M94.97 Disorder of cartilage, unspecified (Ankle and foot)	0.004	0.996	0.000
M94.95 Disorder of cartilage, unspecified (Pelvic region and thigh)	0.004	0.996	0.000
M94.94 Disorder of cartilage, unspecified (Hand)	0.004	0.996	0.000
M94.93 Disorder of cartilage, unspecified (Forearm)	0.004	0.996	0.000
M94.92 Disorder of cartilage, unspecified (Upper arm)	0.004	0.996	0.000
M94.91 Disorder of cartilage, unspecified (Shoulder region)	0.004	0.996	0.000
M94.90 Disorder of cartilage, unspecified (Multiple sites)	0.004	0.996	0.000
Y54.9 Mineral salts, not elsewhere classified	0.004	0.996	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.004	0.996	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.004	0.996	0.000
Y54.0 Mineralocorticoids	0.004	0.996	0.000
Y48 Anaesthetics and therapeutic gases	0.004	0.996	0.000
Y54.7 Agents affecting calcification	0.004	0.996	0.000
Z38 Liveborn infants according to place of birth	0.004	0.996	0.000
M94.08 Chondrocostal junction syndrome [Tietze]-Other	0.004	0.996	0.000
Y42.2 Antithyroid drugs	0.004	0.996	0.000
Y58.0 BCG vaccine	0.004	0.996	0.000
Z39.2 Routine postpartum follow-up	0.004	0.996	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.004	0.996	0.000
Y55.5 Anticommon cold drugs	0.004	0.996	0.000
Y55.4 Expectorants	0.004	0.996	0.000
Y55.3 Antitussives	0.004	0.996	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.004	0.996	0.000
Y55.0 Oxytocic drugs	0.004	0.996	0.000
Z35.8 Supervision of other high-risk pregnancies	0.004	0.996	0.000
S81.0 Open wound of knee	0.004	0.996	0.000
Y41.5 Antiviral drugs	0.004	0.996	0.000
H33.0 Retinal detachment with retinal break	0.000	0.996	0.004
Y49.5 Other antipsychotics and neuroleptics	0.004	0.996	0.000
Z31.2 In vitro fertilisation	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
H33 Retinal detachments and breaks	0.000	0.996	0.004
Z35 Supervision of high-risk pregnancy	0.004	0.996	0.000
M94.07 Chondrocostal junction syndrome [Tietze]-Ankle/foot	0.004	0.996	0.000
M94.06 Chondrocostal junction syndrome [Tietze]-Lower leg	0.004	0.996	0.000
M94.05 Chondrocostal junction syndrome [Tietze]-Pelvic/thigh	0.004	0.996	0.000
M94.04 Chondrocostal junction syndrome [Tietze]-Hand	0.004	0.996	0.000
M94.03 Chondrocostal junction syndrome [Tietze]-Forearm	0.004	0.996	0.000
M94.02 Chondrocostal junction syndrome [Tietze]-Upper arm	0.004	0.996	0.000
M94.01 Chondrocostal junction syndrome [Tietze]-Shldr region	0.004	0.996	0.000
M94.00 Chondrocostal junction syndrome [Tietze]-Mult sites	0.004	0.996	0.000
Y58.9 Other and unspecified bacterial vaccines	0.004	0.996	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.004	0.996	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.004	0.996	0.000
Y58.5 Diphtheria vaccine	0.004	0.996	0.000
Y58.4 Tetanus vaccine	0.004	0.996	0.000
Y58.3 Plague vaccine	0.004	0.996	0.000
Y58.2 Cholera vaccine	0.004	0.996	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.004	0.996	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.004	0.996	0.000
Y50.9 Central nervous system stimulant, unspecified	0.004	0.996	0.000
Y50.8 Other central nervous system stimulants	0.004	0.996	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.004	0.996	0.000
Y50.1 Opioid receptor antagonists	0.004	0.996	0.000
Y50.0 Analeptics	0.004	0.996	0.000
Y40.5 Aminoglycosides	0.004	0.996	0.000
Y49.9 Psychotropic drug, unspecified	0.004	0.996	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
Y49.7 Psychostimulants with abuse potential	0.004	0.996	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.004	0.996	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.004	0.996	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.004	0.996	0.000
Y49.2 Other and unspecified antidepressants	0.004	0.996	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.004	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Z31.6 General counselling and advice on procreation	0.004	0.996	0.000
Z31.5 Genetic counselling	0.004	0.996	0.000
Z31.3 Other assisted fertilisation methods	0.004	0.996	0.000
Z31.1 Artifical insemination	0.004	0.996	0.000
Z39.0 Care and examination immediately after delivery	0.004	0.996	0.000
Z32 Pregnancy examination and test	0.004	0.996	0.000
M94.2 Chondromalacia	0.004	0.996	0.000
Y44.5 Thrombolytic drugs	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.004	0.996	0.000
M94.19 Relapsing polychondritis (Site unspecified)	0.004	0.996	0.000
M94.18 Relapsing polychondritis (Other)	0.004	0.996	0.000
M94.17 Relapsing polychondritis (Ankle and foot)	0.004	0.996	0.000
M94.16 Relapsing polychondritis (Lower leg)	0.004	0.996	0.000
M94.15 Relapsing polychondritis (Pelvic region and thigh)	0.004	0.996	0.000
M94.14 Relapsing polychondritis (Hand)	0.004	0.996	0.000
M94.13 Relapsing polychondritis (Forearm)	0.004	0.996	0.000
M94.12 Relapsing polychondritis (Upper arm)	0.004	0.996	0.000
M94.11 Relapsing polychondritis (Shoulder region)	0.004	0.996	0.000
M94.10 Relapsing polychondritis (Multiple sites)	0.004	0.996	0.000
M94.39 Chondrolysis (Site unspecified)	0.004	0.996	0.000
M94.38 Chondrolysis (Other)	0.004	0.996	0.000
M94.37 Chondrolysis (Ankle and foot)	0.004	0.996	0.000
M94.36 Chondrolysis (Lower leg)	0.004	0.996	0.000
M94.35 Chondrolysis (Pelvic region and thigh)	0.004	0.996	0.000
M94.34 Chondrolysis (Hand)	0.004	0.996	0.000
M94.33 Chondrolysis (Forearm)	0.004	0.996	0.000
M94.32 Chondrolysis (Upper arm)	0.004	0.996	0.000
M94.31 Chondrolysis (Shoulder region)	0.004	0.996	0.000
M94.30 Chondrolysis (Multiple sites)	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y54.4 Loop [high-ceiling] diuretics	0.004	0.996	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
Y41.4 Anthelminthics	0.004	0.996	0.000
Y41.3 Other antiprotozoal drugs	0.004	0.996	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.004	0.996	0.000
R59 Enlarged lymph nodes	0.004	0.996	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.004	0.996	0.000
Y54.3 Benzothiadiazine derivatives	0.004	0.996	0.000
Z31.9 Procreative management, unspecified	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.004	0.996	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.996	0.000
J03.9 Acute tonsillitis, unspecified	0.004	0.996	0.000
Y44.2 Anticoagulants	0.004	0.996	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.996	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.996	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.996	0.000
Y47.4 Bromine compounds	0.003	0.996	0.000
Y47.3 Paraldehyde	0.003	0.996	0.000
Y47.2 Chloral derivatives	0.003	0.996	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.996	0.000
H33.4 Traction detachment of retina	0.000	0.996	0.004
L40.3 Pustulosis palmaris et plantaris	0.003	0.996	0.000
N71.9 Inflammatory disease of uterus, unspecified	0.000	0.996	0.004
Y41.1 Antimycobacterial drugs	0.003	0.996	0.000
C18.1 Appendix	0.003	0.996	0.000
L40.0 Psoriasis vulgaris	0.004	0.996	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.996	0.000
Y42.7 Androgens and anabolic congeners	0.003	0.996	0.000
R59.1 Generalised enlarged lymph nodes	0.004	0.996	0.000
L40.1 Generalised pustular psoriasis	0.003	0.996	0.000
Y57 Other and unspecified drugs and medicaments	0.003	0.996	0.000
S62.40 Multiple fractures of metacarpal bones (closed)	0.003	0.997	0.000
D12.1 Appendix	0.003	0.997	0.000
Z34 Supervision of normal pregnancy	0.002	0.997	0.001
L40.4 Guttate psoriasis	0.003	0.997	0.000
L40.2 Acrodermatitis continua	0.003	0.997	0.000
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
H32 Chorioretinal disorders in diseases classified elsewhere	0.000	0.997	0.003
L81.4 Other melanin hyperpigmentation	0.000	0.997	0.003
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
N71 Inflammatory disease of uterus, except cervix	0.000	0.997	0.003
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.003	0.997	0.000
H33.5 Other retinal detachments	0.000	0.997	0.003
Y48.3 Local anaesthetics	0.003	0.997	0.000
Z38.8 Other multiple, unspecified as to place of birth	0.003	0.997	0.000
Z38.7 Other multiple, born outside hospital	0.003	0.997	0.000
Z38.6 Other multiple, born in hospital	0.003	0.997	0.000
Z38.5 Twin, unspecified as to place of birth	0.003	0.997	0.000
Z38.4 Twin, born outside hospital	0.003	0.997	0.000
Z38.3 Twin, born in hospital	0.003	0.997	0.000
Z38.2 Singleton, unspecified as to place of birth	0.003	0.997	0.000
Z38.1 Singleton, born outside hospital	0.003	0.997	0.000
H33.3 Retinal breaks without detachment	0.000	0.997	0.003
L40.8 Other psoriasis	0.003	0.997	0.000
L92.3 Foreign body granuloma of skin and subcutaneous tissue	0.003	0.997	0.000
Y43 Primarily systemic agents	0.003	0.997	0.000
R47-R49 Symptoms and signs involving speech and voice	0.003	0.997	0.000
S64.1 Injury of median nerve at wrist and hand level	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
Z35.7 Supervision of high-risk pregnancy due to social problems	0.003	0.997	0.000
Z35.6 Supervision of very young primigravida	0.003	0.997	0.000
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.003	0.997	0.000
Y43.0 Antiallergic and antiemetic drugs	0.003	0.997	0.000
Y46.4 Iminostilbenes	0.003	0.997	0.000
Z38.0 Singleton, born in hospital	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Z32.9 Pregnancy confirmed (erroneous code. See Z321)	0.003	0.997	0.000
M94.29 Chondromalacia (Site unspecified)	0.003	0.997	0.000
M94.28 Chondromalacia (Other)	0.003	0.997	0.000
M94.27 Chondromalacia (Ankle and foot)	0.003	0.997	0.000
M94.25 Chondromalacia (Pelvic region and thigh)	0.003	0.997	0.000
M94.24 Chondromalacia (Hand)	0.003	0.997	0.000
M94.23 Chondromalacia (Forearm)	0.003	0.997	0.000
M94.22 Chondromalacia (Upper arm)	0.003	0.997	0.000
M94.21 Chondromalacia (Shoulder region)	0.003	0.997	0.000
M94.20 Chondromalacia (Multiple sites)	0.003	0.997	0.000
Y57.5 X-ray contrast media	0.003	0.997	0.000
C18.6 Descending colon	0.003	0.997	0.000
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.003	0.997	0.000
J33.9 Nasal polyp, unspecified	0.003	0.997	0.000
S64.3 Injury of digital nerve of thumb	0.003	0.997	0.000
H30 Chorioretinal inflammation	0.000	0.997	0.003
H50.9 Strabismus, unspecified	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
H33.1 Retinoschisis and retinal cysts	0.000	0.997	0.003
N71.0 Acute inflammatory disease of uterus	0.000	0.997	0.003
Z35.4 Supervision of pregnancy with grand multiparity	0.003	0.997	0.000
M91-M94 Chondropathies	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
Z32.0 Pregnancy, not (yet) confirmed	0.003	0.997	0.000
Z32.1 Pregnancy confirmed	0.003	0.997	0.000
S64 Injury of nerves at wrist and hand level	0.003	0.997	0.000
Y41.0 Sulphonamides	0.002	0.997	0.000
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.003	0.997	0.000
J32.0 Chronic maxillary sinusitis	0.000	0.997	0.003
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
J04.1 Acute tracheitis	0.003	0.997	0.000
R68.8 Other specified general symptoms and signs	0.003	0.997	0.000
Y40.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
R48 Dyslexia and other symbolic dysfunctions, not elsewhere classified	0.003	0.997	0.000
K72.9 Hepatic failure, unspecified	0.000	0.997	0.003
Z35.9 Supervision of high-risk pregnancy, unspecified	0.003	0.997	0.000
D12.9 Anus and anal canal	0.003	0.997	0.000
Z34.9 Supervision of normal pregnancy, unspecified	0.003	0.997	0.000
M77.4 Metatarsalgia	0.000	0.997	0.003
S62.50 Fracture of thumb (closed)	0.000	0.997	0.003
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.000	0.997	0.002
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.002
Y43.1 Antineoplastic antimetabolites	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.002	0.997	0.000
D33.2 Brain, unspecified	0.003	0.997	0.000
F06.7 Mild cognitive disorder	0.000	0.997	0.003
T85.7 Infection and inflammatory reaction due to other internal prosthetic devices, implants and grafts	0.000	0.997	0.003
Y57.6 Other diagnostic agents	0.002	0.997	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.997	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.997	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.997	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.997	0.000
Y43.2 Antineoplastic natural products	0.002	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.997	0.000
Y53.4 Other laxatives	0.002	0.997	0.000
Y45.0 Opioids and related analgesics	0.002	0.997	0.000
M92 Other juvenile osteochondrosis	0.002	0.997	0.000
Z34.8 Supervision of other normal pregnancy	0.000	0.998	0.002
O72.2 Delayed and secondary postpartum haemorrhage	0.002	0.998	0.000
S61.9 Open wound of wrist and hand, part unspecified	0.000	0.998	0.002
H31 Other disorders of choroid	0.000	0.998	0.002
H30.8 Other chorioretinal inflammations	0.000	0.998	0.002
H30.2 Posterior cyclitis	0.000	0.998	0.002
H30.1 Disseminated chorioretinal inflammation	0.000	0.998	0.002
H30.0 Focal chorioretinal inflammation	0.000	0.998	0.002
R48.0 Dyslexia and alexia	0.002	0.998	0.000
M25.84 Other specified joint disorders (Hand)	0.000	0.998	0.002
S62.51 Fracture of thumb (open)	0.000	0.998	0.002
D33.3 Cranial nerves	0.002	0.998	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.002	0.998	0.000
Y57.8 Other drugs and medicaments	0.002	0.998	0.000
M91 Juvenile osteochondrosis of hip and pelvis	0.002	0.998	0.000
S64.9 Injury of unspecified nerve at wrist and hand level	0.002	0.998	0.000
S64.8 Injury of other nerves at wrist and hand level	0.002	0.998	0.000
Z35.1 Supervision of pregnancy with history of abortive outcome	0.002	0.998	0.000
C83.3 Large cell (diffuse)	0.002	0.998	0.000
N04.9 Unspecified	0.002	0.998	0.000
O86.4 Pyrexia of unknown origin following delivery	0.002	0.998	0.000
F30.0 Hypomania	0.002	0.998	0.000
R48.8 Other and unspecified symbolic dysfunctions	0.002	0.998	0.000
R48.2 Apraxia	0.002	0.998	0.000
R48.1 Agnosia	0.002	0.998	0.000
M77.49 Metatarsalgia-Site unspec	0.000	0.998	0.002
M77.48 Metatarsalgia-Other	0.000	0.998	0.002
M77.46 Metatarsalgia-Lower Leg	0.000	0.998	0.002
M77.45 Metatarsalgia-Pelvic/Thigh	0.000	0.998	0.002
M77.44 Metatarsalgia-Hand	0.000	0.998	0.002
M77.43 Metatarsalgia-Forearm	0.000	0.998	0.002
M77.42 Metatarsalgia-Upper arm	0.000	0.998	0.002
M77.41 Metatarsalgia-Shldr region	0.000	0.998	0.002
M77.40 Metatarsalgia-Mult sites	0.000	0.998	0.002
D33 Benign neoplasm of brain and other parts of central nervous system	0.002	0.998	0.000
R49 Voice disturbances	0.002	0.998	0.000
D33.4 Spinal cord	0.002	0.998	0.000
M92.2 Juvenile osteochondrosis of hand	0.002	0.998	0.000
S64.7 Injury of multiple nerves at wrist and hand level	0.002	0.998	0.000
H33.2 Serous retinal detachment	0.000	0.998	0.002
O86 Other puerperal infections	0.002	0.998	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.002	0.998	0.000
M65.3 Trigger finger	0.000	0.998	0.002
H36 Retinal disorders in diseases classified elsewhere	0.000	0.998	0.002
L40.5 Arthropathic psoriasis	0.002	0.998	0.000
M94.26 Chondromalacia (Lower leg)	0.001	0.998	0.001
M92.6 Juvenile osteochondrosis of tarsus	0.002	0.998	0.000
E89.0 Postprocedural hypothyroidism	0.002	0.998	0.000
M92.5 Juvenile osteochondrosis of tibia and fibula	0.002	0.998	0.000
M92.1 Juvenile osteochondrosis of radius and ulna	0.002	0.998	0.000
M92.9 Juvenile osteochondrosis, unspecified	0.002	0.998	0.000
M92.8 Other specified juvenile osteochondrosis	0.002	0.998	0.000
M92.7 Juvenile osteochondrosis of metatarsus	0.002	0.998	0.000
M92.4 Juvenile osteochondrosis of patella	0.002	0.998	0.000
M92.3 Other juvenile osteochondrosis of upper limb	0.002	0.998	0.000
M92.0 Juvenile osteochondrosis of humerus	0.002	0.998	0.000
J03 Acute tonsillitis	0.002	0.998	0.000
M93 Other osteochondropathies	0.002	0.998	0.000
S62.5 Fracture of thumb	0.000	0.998	0.002
O86.0 Infection of obstetric surgical wound	0.002	0.998	0.000
R49.8 Other and unspecified voice disturbances	0.002	0.998	0.000
H31.9 Disorder of choroid, unspecified	0.000	0.998	0.002
H31.4 Choroidal detachment	0.000	0.998	0.002
H31.3 Choroidal haemorrhage and rupture	0.000	0.998	0.002
H31.2 Hereditary choroidal dystrophy	0.000	0.998	0.002
H31.1 Choroidal degeneration	0.000	0.998	0.002
I97.2 Postmastectomy lymphoedema syndrome	0.002	0.998	0.000
D33.0 Brain, supratentorial	0.002	0.998	0.000
H30.9 Chorioretinal inflammation, unspecified	0.000	0.998	0.002
Z97.5 Presence of (intra-uterine) contraceptive device	0.002	0.998	0.000
S39.9 Unspecified injury of abdomen, lower back and pelvis	0.000	0.998	0.002
Y40.0 Penicillins	0.002	0.998	0.000
Z81.8 Family history of other mental and behavioural disorders	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
O86.2 Urinary tract infection following delivery	0.002	0.998	0.000
W25.9 Unspecified place	0.000	0.998	0.002
Z01.9 Special examination, unspecified	0.002	0.998	0.000
M91.2 Coxa plana	0.002	0.998	0.000
F30.9 Manic episode, unspecified	0.002	0.998	0.000
M91.9 Juvenile osteochondrosis of hip and pelvis, unspecified	0.002	0.998	0.000
M91.8 Other juvenile osteochondrosis of hip and pelvis	0.002	0.998	0.000
M91.3 Pseudocoxalgia	0.002	0.998	0.000
M91.0 Juvenile osteochondrosis of pelvis	0.002	0.998	0.000
Z34.0 Supervision of normal first pregnancy	0.001	0.998	0.001
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
I35.0 Aortic (valve) stenosis	0.002	0.998	0.000
M41.96 Scoliosis, unspecified (Lumbar region)	0.002	0.998	0.000
R68.2 Dry mouth, unspecified	0.002	0.998	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.002	0.998	0.000
D33.9 Central nervous system, unspecified	0.002	0.998	0.000
D33.7 Other specified parts of central nervous system	0.002	0.998	0.000
D33.1 Brain, infratentorial	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations